Improving the Quality of Care: Treatment of Latent Tuberculosis Infection
Post date: February 6, 2023/ Pharmacy Announcements
- Describe populations at high risk for infection with Mycobacterium tuberculosis (M. tuberculosis) and for developing tuberculosis (TB) disease once infected.
- Explain the different testing options for diagnosing latent tuberculosis infection (LTBI), as well as their advantages and limitations.
- Summarize the 2020 guidelines for the treatment of LTBI recommended by the National Tuberculosis Controllers Association and the Centers for Disease Control and Prevention (CDC).
